Pazorest Tablets — Pazopanib 200 mg (28 Tabs) Everest
Pazorest 200 mg (Pazopanib) is a potent multi-kinase inhibitor and a generic equivalent to Votrient. It works by interfering with the growth of cancer cells and cutting off their blood supply.
Manufacturer: Everest Pharmaceuticals (Bangladesh). Pazopanib targets multiple receptors (VEGFR, PDGFR, c-KIT) responsible for tumor angiogenesis and proliferation.
Key Features:
- ✅ Anti-Angiogenesis: Blocks the formation of new blood vessels that tumors need to grow.
- ✅ Broad Efficacy: Proven effective in treating advanced kidney cancer and soft tissue sarcomas.
- ✅ Flexible Dosing: The 200 mg tablet allows for precise dose adjustments to manage side effects.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 21.03.2026
What Customers Say
No reviews yet
Your review can be the first!